Disposition and metabolism of pentamethylmelamine and hexamethylmelamine in rabbits and humans
- PMID: 115586
Disposition and metabolism of pentamethylmelamine and hexamethylmelamine in rabbits and humans
Abstract
The disposition and metabolism of pentamethylmelamine (PMM) and hexamethylmelamine (HMM) were studied in the rabbit, and the disposition of PMM was studied in humans. Parent compound and metabolites were identified by thin-layer chromatography, gas chromatography, and gas chromatography/mass spectrometry analyses. Plasma elimination in both species following i.v. administration of each drug was best described by a two-compartment open model. Both compounds were extensively demethylated with less than 1% of the total dose administered recovered in the urine over 24 hr. The areas under the plasma time-concentration curves of PMM and HMM following p.o. administration to rabbits were 5 and 25% of the areas following i.v. administration. Gastrointestinal absorption was rapid and efficient with 75 to 89% of drug equivalents recoverable in the urine after p.o. administration of [ring-14C]PMM or [ring-14C]HMM to rabbits. Reduced bioavailability of PMM and HMM p.o. appears to be a consequence of rapid metabolism presumably in the liver.
Similar articles
-
Low oral bioavailability of hexamethylmelamine in the rat due to simultaneous hepatic and intestinal metabolism.Cancer Res. 1983 Jul;43(7):3160-4. Cancer Res. 1983. PMID: 6406053
-
First-pass metabolism of pentamethylmelamine in the rat liver.Cancer Res. 1985 Mar;45(3):983-6. Cancer Res. 1985. PMID: 3918792
-
Pharmacokinetics of hexamethylmelamine and pentamethylmelamine in mice.Cancer Treat Rep. 1981 Jul-Aug;65(7-8):669-72. Cancer Treat Rep. 1981. PMID: 6788370
-
Pentamethylmelamine: review of an aqueous analog of hexamethylmelamine.Cancer Treat Rep. 1986 Mar;70(3):383-9. Cancer Treat Rep. 1986. PMID: 3082512 Review.
-
Hexamethylmelamine: pharmacology and mechanism of action.Cancer Treat Rev. 1991 Mar;18 Suppl A:3-14. doi: 10.1016/0305-7372(91)90019-v. Cancer Treat Rev. 1991. PMID: 1904306 Review.
Cited by
-
The comparative pharmacokinetics of pentamethylmelamine in man, rat, and mouse.Cancer Chemother Pharmacol. 1982;8(1):105-11. doi: 10.1007/BF00292880. Cancer Chemother Pharmacol. 1982. PMID: 6807560
-
Hexamethylmelamine and hexamethylmelamine hydrochloride.Pharm Weekbl Sci. 1982 Apr 23;4(2):25-31. doi: 10.1007/BF01963657. Pharm Weekbl Sci. 1982. PMID: 6808457 Review.
-
N-methyl antitumour agents. A distinct class of anticancer drugs?Cancer Chemother Pharmacol. 1987;19(2):91-102. doi: 10.1007/BF00254559. Cancer Chemother Pharmacol. 1987. PMID: 3552281 Review.
-
Dose-dependent pharmacokinetics of PMM in the rat.Cancer Chemother Pharmacol. 1981;5(3):201-3. doi: 10.1007/BF00258481. Cancer Chemother Pharmacol. 1981. PMID: 6794923
-
Increased nephrotoxicity after combined administration of melamine and cyanuric Acid in rats.Lab Anim Res. 2011 Mar;27(1):25-8. doi: 10.5625/lar.2011.27.1.25. Epub 2011 Mar 26. Lab Anim Res. 2011. PMID: 21826156 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources